Geron Corporation is a biotechnology company focused on developing innovative therapies for cancer treatment, particularly through its lead product candidate, which targets hematologic malignancies
The company is dedicated to advancing its proprietary telomerase technology to create effective and safe treatment options for patients with various types of cancer. By leveraging its scientific expertise and clinical research capabilities, Geron aims to address unmet medical needs and improve patient outcomes in the oncology field.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a broader market where technology rules.
